| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from exercise of forward purchase agreement warrants | 158 | - |
| Proceeds from the issuance of common stock and investor warrants from registered direct offering | 2,500 | - |
| Net cash provided by financing activities | 10,593 | 7,992 |
| Effect of exchange rate changes on cash | 3 | 4 |
| Net (decrease) increase in cash | -1,927 | -196 |
| Cash and cash equivalents at beginning of period | 5,483 | - |
| Cash and cash equivalents at end of period | 3,556 | - |
Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. (COCH)